Odronextamab Recommended for EU Approval by the Chmp to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
Odronextamab獲歐洲藥品管理局建議批准,用於治療復發/難治性濾泡性淋巴瘤和瀰漫性大B細胞淋巴瘤
Odronextamab Recommended for EU Approval by the Chmp to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
Odronextamab獲歐洲藥品管理局建議批准,用於治療復發/難治性濾泡性淋巴瘤和瀰漫性大B細胞淋巴瘤
譯文內容由第三人軟體翻譯。